Rocket


Overview
Financials
News + Filings
Key Docs
Charts
Ownership
Insiders





All
All (ex-4s)
10-K
10-Q
8-K
3,4,5
Proxy
Prospectus
Other

Tags
Acq. completed
Quarterly results
CC transcript

PETMED EXPRESS INC (PETS) Create: Alert

All | News | Filings
Date FiledTypeDescription
08/16/2023 4 Smith Jacqueline Paula (Vice President of People) has filed a Form 4 on PETMED EXPRESS INC
Txns: Granted 6,000 shares @ $0
08/16/2023 4 Smith Jacqueline Paula (Vice President of People) has filed a Form 4 on PETMED EXPRESS INC
Txns: Granted 7,350 shares @ $21.76, valued at $159.9k
08/04/2023 8-K Submission of Matters to a Vote of Security Holders  Interactive Data
08/04/2023 4 Campbell Leslie C.G. (Director) has filed a Form 4 on PETMED EXPRESS INC
Txns: Granted 7,500 shares @ $0
08/04/2023 4 Campos Sandra Yvette (Director) has filed a Form 4 on PETMED EXPRESS INC
Txns: Granted 7,500 shares @ $0
08/04/2023 4 FULGONI GIAN (Director) has filed a Form 4 on PETMED EXPRESS INC
Txns: Granted 7,500 shares @ $0
08/04/2023 4 PURCEL DIANA G (Director) has filed a Form 4 on PETMED EXPRESS INC
Txns: Granted 7,500 shares @ $0
08/01/2023 10-Q Quarterly Report for the period ended June 30, 2023
07/31/2023 8-K Quarterly results
07/07/2023 SC 13G/A BlackRock Inc. reports a 8% stake in PETMED EXPRESS INC
06/12/2023 4 Chambers Christine (CFO) has filed a Form 4 on PETMED EXPRESS INC
Txns: Disposed/sold 3,000 shares @ $0
05/26/2023 8-K Results of Operations and Financial Condition, Financial Statements and Exhibits  Interactive Data
Docs: "PETMED EXPRESS, INC. QUARTER AND YEAR ENDED MARCH 31, 2023"
05/24/2023 4 Pingree Daniel Job (Chief Marketing Officer) has filed a Form 4 on PETMED EXPRESS INC
Txns: Granted 11,000 shares @ $15.48, valued at $170.3k
05/23/2023 10-K Annual Report for the period ended March 31, 2023
05/23/2023 4 Form 4 - Statement of changes in beneficial ownership of securities:
05/18/2023 8-K Departure of Directors or Certain Officers; Election of Directors; Appointment of Certain Officers: Compensatory Arrangements...
Docs: "PetMeds® Appoints Sandra Y. Campos to its Board of Directors Ms. Campos joins as an independent director, bringing years of executive leadership experience in digital transformations and turnarounds"
04/03/2023 8-K Regulation FD Disclosure, Other Events  Interactive Data
02/09/2023 S-8 Form S-8 - Securities to be offered to employees in employee benefit plans:
02/07/2023 10-Q Quarterly Report for the period ended December 31, 2022
02/06/2023 8-K Quarterly results
01/26/2023 SC 13G/A ProShare Advisors LLC reports a 3.2% stake in PETMED EXPRESS INC
01/23/2023 SC 13G/A BlackRock Inc. reports a 16.5% stake in PETMED EXPRESS INC
01/19/2023 8-K Regulation FD Disclosure  Interactive Data
Docs: "Analyst Day January 2023 NASDAQ: PETS"
01/17/2023 8-K Quarterly results
11/08/2022 10-Q Quarterly Report for the period ended September 30, 2022
11/07/2022 8-K Quarterly results
Docs: "PetMeds® Announces Its Second Quarter Financial Results and Declares a Quarterly Dividend of $0.30 Per Share"
08/10/2022 3 Chambers Christine (CFO) has filed a Form 3 on PETMED EXPRESS INC
08/03/2022 8-K Departure of Directors or Certain Officers; Election of Directors; Appointment of Certain Officers: Compensatory Arrangements...
Docs: " ",
" ",
" "
08/02/2022 8-K Departure of Directors or Certain Officers; Election of Directors; Appointment of Certain Officers: Compensatory Arrangements...
Docs: " "
08/02/2022 10-Q Quarterly Report for the period ended June 30, 2022
08/01/2022 4 Cobb Peter (Director) has filed a Form 4 on PETMED EXPRESS INC
Txns: Granted 7,500 shares @ $21.76, valued at $163.2k
08/01/2022 4 Campbell Leslie C.G. (Director) has filed a Form 4 on PETMED EXPRESS INC
Txns: Granted 7,500 shares @ $21.76, valued at $163.2k
08/01/2022 4 Watson Jodi (Director) has filed a Form 4 on PETMED EXPRESS INC
Txns: Granted 7,500 shares @ $21.76, valued at $163.2k
08/01/2022 4 FULGONI GIAN (Director) has filed a Form 4 on PETMED EXPRESS INC
Txns: Granted 7,500 shares @ $21.76, valued at $163.2k
  Next >>

Rocket Data Systems, Inc. © 2019 | Contact Us | Data Disclaimer | Terms of Use | Privacy